A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

This is a Phase 1 safety study of a new experimental cancer drug called LXP1788 in adults with advanced solid tumors (cancers that form a lump, as opposed to blood cancers) that have stopped responding to all available treatments. **You may be eligible if...** - You are 18 or older - You have an advanced solid tumor confirmed by biopsy that has not responded to existing treatments - Your cancer can be measured on scans - You are in reasonably good overall health (able to care for yourself) - Your life expectancy is more than 8 weeks - You are willing to have a tumor biopsy or have one available from within the past 3 years **You may NOT be eligible if...** - You have significant heart, lung, kidney, or liver problems - Your cancer has spread to the brain in a way causing active symptoms - You have HIV, active hepatitis B or C - You are pregnant or breastfeeding - You had major surgery within the past 4 weeks Talk to your doctor to see if this trial is right for you.